Cardiac amyloidosis presenting with coronary artery embolization
Christos Papageorgiou1, Eleftheria Tsagalou2, Ioannis Baraboutis3
1Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Insights
Amyloid light-chain amyloidosis can cause ST-elevation myocardial infarction through coronary artery embolization. Early diagnosis and multidisciplinary care are crucial for managing this rare cardiovascular complication.
Area of Science:
- Cardiology
- Oncology
- Hematology
Background:
- Amyloid light-chain (AL) amyloidosis is a systemic disease with varied clinical presentations.
- Thromboembolic events, including arterial events, are known manifestations of AL amyloidosis.
Observation:
- A 57-year-old female presented with ST-elevation myocardial infarction (STEMI).
- Coronary angiography revealed embolization in the left anterior descending artery.
- Cardiac imaging showed left ventricular hypertrophy, impaired systolic function, and restrictive filling patterns.
Findings:
- Cardiac magnetic resonance imaging indicated microvascular infarction and apex infarct, suggestive of amyloidosis.
- Fat tissue biopsy confirmed AL amyloidosis.
- The patient received anticoagulation, heart failure therapy, and anti-plasma cell treatment.
Implications:
- Amyloidosis should be considered in the differential diagnosis of coronary artery embolization and myocardial infarction.
- Multidisciplinary collaboration between cardiologists and oncologists is essential for accurate diagnosis and management.
- Prompt treatment led to clinical improvement and freedom from cardiovascular events for 12 months.
Abstract:
Amyloid light-chain (AL) amyloidosis is a multisystemic disease. Among its clinical manifestations, vein and arterial thromboembolic events are included. We report the unusual case of a 57-year-old female patient with AL amyloidosis presenting with an ST segment elevation myocardial infarction due to coronary artery embolization (CE). The patient reported a history of exertional dyspnoea along with episodes of haemoptysis for the last few months. Her coronary angiography demonstrated embolization of the distal segment of the left anterior descending artery. The main findings of her cardiac ultrasound included concentric left ventricular hypertrophy, mildly impaired left ventricular systolic function, left atrium enlargement and a restrictive-like filling pattern, while her chest computed tomography (CT) demonstrated bilateral pleural effusions. Cardiac magnetic resonance imaging that was performed afterwards, indicated areas of microvascular infarction, a small apex infarct and findings compatible with possible amyloidosis, a diagnosis that was confirmed later by fat tissue biopsy. Patient was referred for an oncology consultation, started therapy with direct oral anticoagulants, angiotensin converting enzyme inhibitor, statins and anti-plasma cell therapy. She has been improving since then and has been free of cardiovascular events for a follow-up period of 12 months. Cardiologists ought to be aware of amyloidosis as a rare but possible cause of coronary embolization, while close collaboration with oncologists is required for the establishment of the correct diagnosis.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy


